Zhang et al reported a model for predicting the risk of early death for a patient with acute promyelocytic leukemia (APML). This can help to identify a patient who may benefit from more agressive management. The authors are Harbin Medical University, The First Affiliated Hospital and The Fourth Affiliated Hospital in Harbin, China.